MedTrace Logo

Creatine and GAA for Brain Oxygenation

NCT06371651 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2024-05-09

No results posted yet for this study

Summary

The main aim of this randomized controlled trial is to evaluate cerebral blood oxygenation after 7-day administration of a creatine-guanidinoacetic acid (GAA) mixture in healthy adults before, during, and after a series of cognitive tests.

Conditions

  • Oxygen Deficiency

Interventions

DIETARY_SUPPLEMENT

Supplement

Dietary supplement containing creatine and guanidinoacetic acid

DIETARY_SUPPLEMENT

Placebo

Inert substance

Sponsors & Collaborators

  • University of Novi Sad, Faculty of Sport and Physical Education

    lead OTHER

Principal Investigators

  • Sergej Ostojic, MD, PhD · University of Novi Sad

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2024-04-10
Completion
2024-04-12

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06371651 on ClinicalTrials.gov